| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Protease | 22 | 2025 | 125 | 3.750 |
Why?
|
| Drug Resistance, Viral | 25 | 2025 | 160 | 3.280 |
Why?
|
| HIV Protease Inhibitors | 16 | 2025 | 109 | 2.900 |
Why?
|
| Antiviral Agents | 21 | 2025 | 330 | 2.280 |
Why?
|
| Protease Inhibitors | 14 | 2025 | 106 | 1.930 |
Why?
|
| Models, Molecular | 35 | 2025 | 1174 | 1.650 |
Why?
|
| Molecular Dynamics Simulation | 18 | 2025 | 131 | 1.400 |
Why?
|
| Viral Nonstructural Proteins | 12 | 2022 | 94 | 1.290 |
Why?
|
| HIV-1 | 15 | 2021 | 727 | 1.290 |
Why?
|
| Drug Design | 8 | 2022 | 139 | 1.190 |
Why?
|
| Protein Binding | 36 | 2025 | 1651 | 1.140 |
Why?
|
| Catalytic Domain | 20 | 2025 | 207 | 1.070 |
Why?
|
| Protein Conformation | 22 | 2025 | 792 | 0.980 |
Why?
|
| Mutation | 22 | 2025 | 2688 | 0.960 |
Why?
|
| Quinoxalines | 8 | 2022 | 37 | 0.960 |
Why?
|
| DNA, Single-Stranded | 7 | 2021 | 108 | 0.940 |
Why?
|
| Crystallography, X-Ray | 23 | 2025 | 442 | 0.940 |
Why?
|
| Peptides | 5 | 2013 | 603 | 0.890 |
Why?
|
| Hepatitis C | 4 | 2021 | 153 | 0.850 |
Why?
|
| Drug Resistance | 4 | 2024 | 156 | 0.840 |
Why?
|
| Hepacivirus | 9 | 2022 | 139 | 0.800 |
Why?
|
| Models, Chemical | 3 | 2008 | 140 | 0.720 |
Why?
|
| Cytidine Deaminase | 5 | 2025 | 86 | 0.700 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2019 | 116 | 0.690 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 3 | 2020 | 38 | 0.680 |
Why?
|
| Protein Folding | 9 | 2014 | 268 | 0.630 |
Why?
|
| Sulfonamides | 7 | 2022 | 138 | 0.620 |
Why?
|
| Substrate Specificity | 14 | 2024 | 344 | 0.610 |
Why?
|
| Darunavir | 7 | 2025 | 32 | 0.600 |
Why?
|
| Leucine | 7 | 2025 | 67 | 0.560 |
Why?
|
| Serine Endopeptidases | 8 | 2022 | 124 | 0.560 |
Why?
|
| Escherichia coli | 5 | 2021 | 728 | 0.550 |
Why?
|
| Binding Sites | 17 | 2025 | 930 | 0.550 |
Why?
|
| Machine Learning | 5 | 2025 | 195 | 0.550 |
Why?
|
| Apoproteins | 5 | 2011 | 18 | 0.540 |
Why?
|
| Myoglobin | 5 | 2011 | 29 | 0.540 |
Why?
|
| Viral Proteins | 3 | 2025 | 270 | 0.520 |
Why?
|
| Peptide Hydrolases | 4 | 2025 | 80 | 0.500 |
Why?
|
| Proteins | 5 | 2018 | 764 | 0.490 |
Why?
|
| Enterovirus D, Human | 3 | 2025 | 11 | 0.480 |
Why?
|
| Cysteine Endopeptidases | 3 | 2025 | 97 | 0.470 |
Why?
|
| Structure-Activity Relationship | 9 | 2021 | 388 | 0.460 |
Why?
|
| Proline | 5 | 2025 | 49 | 0.460 |
Why?
|
| Amino Acid Sequence | 12 | 2021 | 1618 | 0.460 |
Why?
|
| Evolution, Molecular | 3 | 2014 | 350 | 0.450 |
Why?
|
| HIV Infections | 6 | 2020 | 965 | 0.450 |
Why?
|
| Enzyme Inhibitors | 3 | 2025 | 376 | 0.450 |
Why?
|
| Lactams, Macrocyclic | 5 | 2022 | 31 | 0.430 |
Why?
|
| Cyclopropanes | 5 | 2022 | 55 | 0.430 |
Why?
|
| Nelfinavir | 1 | 2014 | 7 | 0.430 |
Why?
|
| Ribosomes | 2 | 2014 | 173 | 0.420 |
Why?
|
| Thermodynamics | 10 | 2016 | 199 | 0.400 |
Why?
|
| Escherichia coli Proteins | 4 | 2013 | 278 | 0.380 |
Why?
|
| Aminoisobutyric Acids | 3 | 2022 | 9 | 0.370 |
Why?
|
| Dengue Virus | 2 | 2017 | 99 | 0.360 |
Why?
|
| DNA Helicases | 1 | 2013 | 198 | 0.350 |
Why?
|
| Peptide Chain Elongation, Translational | 2 | 2014 | 12 | 0.340 |
Why?
|
| Humans | 45 | 2025 | 65551 | 0.340 |
Why?
|
| Trans-Activators | 1 | 2013 | 322 | 0.340 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2006 | 81 | 0.340 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2020 | 10 | 0.330 |
Why?
|
| Molecular Docking Simulation | 6 | 2022 | 83 | 0.330 |
Why?
|
| APOBEC-3G Deaminase | 2 | 2020 | 21 | 0.320 |
Why?
|
| Polyproteins | 2 | 2016 | 8 | 0.300 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 34 | 0.280 |
Why?
|
| Globins | 3 | 2014 | 25 | 0.280 |
Why?
|
| Protein Biosynthesis | 2 | 2013 | 333 | 0.270 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2018 | 44 | 0.270 |
Why?
|
| Antibodies, Neutralizing | 2 | 2020 | 218 | 0.260 |
Why?
|
| Drug Discovery | 4 | 2021 | 100 | 0.250 |
Why?
|
| Static Electricity | 5 | 2021 | 169 | 0.240 |
Why?
|
| Dengue | 1 | 2016 | 96 | 0.240 |
Why?
|
| Coronavirus, Feline | 1 | 2025 | 2 | 0.240 |
Why?
|
| Serine Proteases | 3 | 2021 | 12 | 0.240 |
Why?
|
| Amino Acid Substitution | 4 | 2019 | 240 | 0.240 |
Why?
|
| APOBEC Deaminases | 2 | 2025 | 11 | 0.230 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2019 | 296 | 0.230 |
Why?
|
| Mutation, Missense | 3 | 2019 | 189 | 0.230 |
Why?
|
| Cytidine | 3 | 2025 | 15 | 0.230 |
Why?
|
| Kinetics | 8 | 2018 | 768 | 0.230 |
Why?
|
| RNA | 2 | 2019 | 432 | 0.220 |
Why?
|
| Cytosine | 1 | 2025 | 31 | 0.220 |
Why?
|
| Valine | 2 | 2021 | 33 | 0.210 |
Why?
|
| Protein Structure, Secondary | 8 | 2017 | 261 | 0.210 |
Why?
|
| Ribonucleoproteins | 1 | 2025 | 117 | 0.210 |
Why?
|
| Gene Products, pol | 1 | 2003 | 9 | 0.200 |
Why?
|
| Electrochemistry | 1 | 2003 | 27 | 0.200 |
Why?
|
| Gene Products, gag | 1 | 2003 | 67 | 0.200 |
Why?
|
| Flavivirus | 1 | 2022 | 8 | 0.190 |
Why?
|
| Amino Acids | 2 | 2018 | 149 | 0.190 |
Why?
|
| Furans | 2 | 2020 | 33 | 0.190 |
Why?
|
| Zika Virus | 1 | 2022 | 37 | 0.180 |
Why?
|
| Zika Virus Infection | 1 | 2022 | 38 | 0.180 |
Why?
|
| Computer Simulation | 5 | 2017 | 487 | 0.180 |
Why?
|
| Swine | 1 | 2023 | 397 | 0.180 |
Why?
|
| Pyrrolidinones | 1 | 2021 | 11 | 0.180 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 23 | 0.180 |
Why?
|
| Isoxazoles | 1 | 2021 | 14 | 0.180 |
Why?
|
| Phenylalanine | 1 | 2021 | 26 | 0.180 |
Why?
|
| Macrocyclic Compounds | 1 | 2021 | 12 | 0.180 |
Why?
|
| Drug Resistance, Fungal | 1 | 2021 | 10 | 0.170 |
Why?
|
| Mammals | 1 | 2023 | 224 | 0.170 |
Why?
|
| Pneumocystis carinii | 1 | 2021 | 8 | 0.170 |
Why?
|
| Subtilisin | 1 | 2001 | 1 | 0.170 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2021 | 5 | 0.170 |
Why?
|
| Herbicides | 1 | 2021 | 20 | 0.170 |
Why?
|
| Pandemics | 2 | 2023 | 676 | 0.170 |
Why?
|
| Nucleoside-Triphosphatase | 5 | 2020 | 40 | 0.170 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2021 | 37 | 0.170 |
Why?
|
| Lactams | 3 | 2025 | 24 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 376 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 99 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 45 | 0.160 |
Why?
|
| Gene Editing | 1 | 2025 | 333 | 0.160 |
Why?
|
| Pesticides | 1 | 2021 | 57 | 0.160 |
Why?
|
| DEAD-box RNA Helicases | 5 | 2020 | 131 | 0.160 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 2016 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2021 | 120 | 0.160 |
Why?
|
| Peptide Fragments | 3 | 2014 | 421 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 682 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 122 | 0.150 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 103 | 0.150 |
Why?
|
| Animals | 11 | 2025 | 21532 | 0.150 |
Why?
|
| Epitopes | 2 | 2020 | 294 | 0.150 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 117 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2019 | 44 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 154 | 0.150 |
Why?
|
| Influenza A Virus, H7N9 Subtype | 1 | 2018 | 7 | 0.140 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 36 | 0.140 |
Why?
|
| Drug Resistance, Multiple, Viral | 1 | 2018 | 14 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.140 |
Why?
|
| Hydrogen Bonding | 4 | 2021 | 129 | 0.140 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 4 | 2018 | 279 | 0.140 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 34 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2017 | 59 | 0.130 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 185 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 24 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2017 | 57 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 101 | 0.130 |
Why?
|
| Amino Acid Motifs | 3 | 2018 | 157 | 0.130 |
Why?
|
| Carbamates | 4 | 2020 | 26 | 0.130 |
Why?
|
| Neuraminidase | 1 | 2016 | 43 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 58 | 0.120 |
Why?
|
| Protein Denaturation | 3 | 2019 | 67 | 0.120 |
Why?
|
| Lipoproteins | 1 | 2016 | 85 | 0.120 |
Why?
|
| Entropy | 2 | 2014 | 24 | 0.120 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 82 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 2016 | 200 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 877 | 0.120 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2016 | 125 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 325 | 0.120 |
Why?
|
| HEK293 Cells | 3 | 2025 | 630 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 682 | 0.120 |
Why?
|
| Molecular Structure | 3 | 2021 | 395 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 250 | 0.120 |
Why?
|
| Borrelia burgdorferi | 1 | 2016 | 93 | 0.110 |
Why?
|
| Influenza A virus | 1 | 2016 | 126 | 0.110 |
Why?
|
| Lyme Disease | 1 | 2016 | 123 | 0.110 |
Why?
|
| Enterovirus Infections | 2 | 2025 | 12 | 0.110 |
Why?
|
| DNA | 1 | 2019 | 855 | 0.110 |
Why?
|
| Archaea | 1 | 2014 | 10 | 0.110 |
Why?
|
| Genotype | 1 | 2016 | 679 | 0.110 |
Why?
|
| Nitriles | 2 | 2025 | 84 | 0.110 |
Why?
|
| Water | 4 | 2019 | 318 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1224 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2021 | 3152 | 0.100 |
Why?
|
| Amides | 3 | 2020 | 61 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 146 | 0.090 |
Why?
|
| Neoplasms | 1 | 2021 | 1415 | 0.080 |
Why?
|
| Ligands | 2 | 2019 | 420 | 0.080 |
Why?
|
| Plant Proteins | 2 | 2001 | 93 | 0.080 |
Why?
|
| Orthomyxoviridae | 2 | 2021 | 28 | 0.080 |
Why?
|
| Biocatalysis | 2 | 2019 | 50 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 87 | 0.070 |
Why?
|
| Deamination | 2 | 2019 | 11 | 0.070 |
Why?
|
| Protein Domains | 2 | 2020 | 155 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2008 | 193 | 0.070 |
Why?
|
| Dihydropteridine Reductase | 1 | 2007 | 1 | 0.070 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2007 | 18 | 0.070 |
Why?
|
| Hemeproteins | 1 | 2007 | 17 | 0.070 |
Why?
|
| Computational Biology | 2 | 2021 | 364 | 0.070 |
Why?
|
| Zinc | 2 | 2020 | 95 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2017 | 369 | 0.060 |
Why?
|
| Sulfonic Acids | 1 | 2025 | 11 | 0.060 |
Why?
|
| Solvents | 1 | 2005 | 60 | 0.060 |
Why?
|
| Cats | 1 | 2025 | 92 | 0.060 |
Why?
|
| Urea | 1 | 2005 | 42 | 0.060 |
Why?
|
| Indoles | 1 | 2025 | 119 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2025 | 66 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 2 | 2016 | 101 | 0.050 |
Why?
|
| Microsomes | 1 | 2013 | 11 | 0.050 |
Why?
|
| Energy Transfer | 1 | 2003 | 10 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2003 | 47 | 0.050 |
Why?
|
| Motion | 1 | 2003 | 65 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2025 | 228 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 162 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2003 | 392 | 0.050 |
Why?
|
| Halogenation | 1 | 2022 | 6 | 0.050 |
Why?
|
| Fluorine | 1 | 2022 | 9 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2018 | 468 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2021 | 22 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 94 | 0.040 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2020 | 22 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 82 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 130 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 137 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2025 | 723 | 0.040 |
Why?
|
| Dipeptides | 1 | 2020 | 68 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 631 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 263 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 1999 | 96 | 0.040 |
Why?
|
| Methionine | 1 | 2019 | 57 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2024 | 574 | 0.040 |
Why?
|
| Sperm Whale | 2 | 2011 | 3 | 0.040 |
Why?
|
| Virion | 1 | 2019 | 122 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 461 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2018 | 81 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 272 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 2017 | 14 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2017 | 103 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 2018 | 0.030 |
Why?
|
| Time Factors | 2 | 2005 | 3788 | 0.030 |
Why?
|
| Proteolysis | 1 | 2018 | 159 | 0.030 |
Why?
|
| Aprotinin | 1 | 2017 | 11 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2017 | 171 | 0.030 |
Why?
|
| Mice | 2 | 2025 | 11208 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 243 | 0.030 |
Why?
|
| Surface Properties | 1 | 2018 | 285 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 306 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 388 | 0.030 |
Why?
|
| Zanamivir | 1 | 2016 | 5 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2016 | 22 | 0.030 |
Why?
|
| Oseltamivir | 1 | 2016 | 35 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 252 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 713 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 147 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 645 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 867 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2016 | 212 | 0.030 |
Why?
|
| Atazanavir Sulfate | 1 | 2013 | 2 | 0.020 |
Why?
|
| Models, Biological | 1 | 2018 | 1217 | 0.020 |
Why?
|
| Calorimetry | 1 | 2012 | 40 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 106 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2013 | 135 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 165 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 117 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 192 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 48 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 257 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 95 | 0.020 |
Why?
|
| Protein Renaturation | 1 | 2005 | 4 | 0.010 |
Why?
|
| Buffers | 1 | 2005 | 23 | 0.010 |
Why?
|
| Chromatography | 1 | 2005 | 16 | 0.010 |
Why?
|
| Biophysics | 1 | 2005 | 42 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2005 | 72 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2005 | 108 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 253 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 141 | 0.010 |
Why?
|
| Light | 1 | 2005 | 206 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 316 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 312 | 0.010 |
Why?
|
| Male | 1 | 2021 | 31081 | 0.010 |
Why?
|